OxGene and Native Antigen Company Collaborate to Increase Covid-19 Antigen Production
The shared goal is to deliver high-purity, recombinant proteins for the development of covid-19 diagnostics and vaccines.
Read MorePosted by | Apr 13, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The shared goal is to deliver high-purity, recombinant proteins for the development of covid-19 diagnostics and vaccines.
Read MorePosted by | Apr 13, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The ANSI portal now includes 36 international standards covering medical equipment and devices.
Read MorePosted by | Apr 10, 2020 | Blood Banking, Covid 19, Emerging & Zoonotic Diseases, Hematology & Serology, Infectious Diseases |
Based on recently completed studies and epidemiologic data, FDA has concluded that current policies regarding certain donor eligibility criteria can be modified without compromising the safety of the blood supply.
Read MorePosted by | Apr 10, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The goal of the rapid test is to provide healthcare professionals with an accurate, fast, and resource-efficient method to detect coronavirus infections early.
Read MorePosted by | Apr 8, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Computational (in silico) design allows for rapid iteration around potential solutions without the unique variables that traditional in vivo subjects may possess.
Read More